Standard BioTools's total assets for Q1 2026 were $639.11M, an increase of 12.57% from the previous quarter. LAB total liabilities were $77.99M for the fiscal quarter, a -45.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.